Selective mutism and obsessive compulsive disorders associated with zonisamide

被引:13
作者
Hirai, K
Kimiya, S
Tabata, K
Seki, T
Jozaki, K
Kumagai, N
机构
[1] Shimada Ryouiku Ctr, Tokyo 2060036, Japan
[2] Keio Univ, Sch Med, Dept Paediat, Shinjuku Ku, Tokyo 1608582, Japan
[3] Hiratsuka Kyousai Hosp, Dept Paediat, Hiratsuka, Kanagawa 2540047, Japan
来源
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 2002年 / 11卷 / 07期
关键词
epilepsy; zonisamide; adverse effects; behaviour disturbance; selective mutism; obsessive compulsive disorders (OCD);
D O I
10.1053/seiz.2001.0625
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We treated 27 children with idiopathic epilepsy with zonisamide monotherapy over a period of 2 years and observed behaviour disturbances in a prospective study. In all cases, seizure control was excellent; however, two cases (7.4%) had behaviour disturbances. The first (Case 1) was a 14-year-old girl with partial epilepsy which began at age 4 years. Zonisamide was administered at age 6 years, which was effective against her seizures, but selective mutism, violent behaviour, and lack of concentration developed at age 10 years. The second (Case 2) was a 15-year-old girl with generalized tonic-clonic seizures which began at age 10 years. Zonisamide was also effective against her seizures, but obsessive compulsive disorders (OCD) developed at age 13 years. The patients have had no other physical or mental problems and decreasing the dosage of zonisamide reduced the problems. There are few reports of behaviour disturbances provoked by zonisamide monotherapy in epileptic children who are neither physically nor mentally disturbed. While problems can develop several years later, in the present study, decreasing the zonisamide dosage maintained adequate prevention of seizures and eliminated the behaviour disturbances. Zonisamide is still a useful anticonvulsant for epileptic seizures, but physicians should be wary of its adverse behavioural side effects, which may arise several years later. (C) 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:468 / 470
页数:3
相关论文
共 11 条
[1]   ZONISAMIDE-INDUCED BEHAVIOR DISORDER IN 2 CHILDREN [J].
KIMURA, S .
EPILEPSIA, 1994, 35 (02) :403-405
[2]   Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures [J].
Kochak, GM ;
Page, JG ;
Buchanan, RA ;
Peters, R ;
Padgett, CS .
JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (02) :166-171
[3]  
Koopowitz L F, 1997, Ann Clin Psychiatry, V9, P171, DOI 10.3109/10401239709147793
[4]  
KUMAGAI N, 1991, JPN J PSYCHIAT NEUR, V45, P357
[5]   Clinical pharmacology and therapeutic drug monitoring of zonisamide [J].
Mimaki, T .
THERAPEUTIC DRUG MONITORING, 1998, 20 (06) :593-597
[6]  
MIMAKI T, 1992, RECENT DEV THERAPEUT, P437
[7]   Psychotic episodes during zonisamide treatment [J].
Miyamoto, T ;
Kohsaka, M ;
Koyama, T .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2000, 9 (01) :65-70
[8]  
Taira T, 1992, No To Shinkei, V44, P61
[9]  
TOONE B, 1981, EPILEPSY PSYCHIATRY, P113
[10]   Psychiatric symptoms after therapy with new antiepileptic drugs:: Psychopathological and seizure related variables [J].
Trimble, MR ;
Rüsch, N ;
Betts, T ;
Crawford, PM .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2000, 9 (04) :249-254